Syndax Pharmaceuticals Inc. (SNDX)
Market Closed
3 Jun, 20:00
$
18. 34
-0.05
-0.27%
After Hours
$
+0.16 +0.87% 18. 50
1.63B Market Cap
- P/E Ratio
- Div Yield
1,245,512 Volume
-2.96 Eps
$ 18.39
Previous Close 
Want to track SNDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Syndax Pharmaceuticals Inc. (SNDX) Statistics
Valuation metrics
Market Cap 1.63B
Enterprise value 1.84B
Trailing P/E (ttm) -6.15
Forward P/E -90.26
PEG ratio 0.12
Price/Sales (ttm) 8.38
Price/Book (mrq) 27.81
Enterprise Value/Revenue 8.45
Enterprise Value/EBITDA -8.19
Overview
Shares outstanding 88.54M
Float 75.1M
Shares short 19.91M
% Held by insiders 0.02%
% Held by institutions 1.16%
Average volume (10 days) 2.11M
Average volume (90 days) 1.67M
Price summary
52-Week low 8.59
52-Week high 25.59
Beta 0.41
50-Day moving average 22.89
200-Day moving average 18.86
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.12%
Operating margin -0.53%
Operational effectiveness
Return on assets -0.25%
Return on equity -1.9%
Income Statement
Revenue (ttm) 217.17M
Revenue per share (ttm) 2.49
Quarterly revenue growth (yoy) 2.24%
Gross profit (ttm) -50.33M
EBITDA -224.17M
Net income to common (ttm) -243.25M
Diluted EPS (ttm) -2.79
Quarterly earnings growth (yoy) 2.24%
Balance Sheet
Total cash (mrq) 361.24M
Total cash per share (mrq) 4.08
Total debt (mrq) 345.36M
Total Debt/Equity (mrq) 829.75
Current ratio (mrq) 5.47%
Book value per share (mrq) 0.74
Cash Flow
Cash flow statement -278.16M
Levered free cash flow (LFCF) -186.26M
